| A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review E Whiskey, U Werneke, D Taylor International clinical psychopharmacology 16 (5), 239-252, 2001 | 216 | 2001 |
| Reasons for discontinuing clozapine: matched, case–control comparison with risperidone long-acting injection DM Taylor, P Douglas-Hall, B Olofinjana, E Whiskey, A Thomas The British Journal of Psychiatry 194 (2), 165-167, 2009 | 111 | 2009 |
| Restarting clozapine after neutropenia: evaluating the possibilities and practicalities E Whiskey, D Taylor CNS drugs 21, 25-35, 2007 | 108 | 2007 |
| The South London and Maudsley NHS Trust: Maudsley Prescribing Guidelines 2003 D Taylor, C Paton, R Kerwin Martin Dunitz, 2003 | 95* | 2003 |
| A review of the adverse effects and safety of noradrenergic antidepressants E Whiskey, D Taylor Journal of Psychopharmacology 27 (8), 732-739, 2013 | 82 | 2013 |
| Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis N Meyer, S Gee, E Whiskey, D Taylor, A Mijovic, F Gaughran, S Shergill, ... The Journal of Clinical Psychiatry 76 (11), 13499, 2015 | 61 | 2015 |
| ‘Restoring the person's life’: a qualitative study to inform development of care for people with severe mental disorders in rural Ethiopia S Mall, M Hailemariam, M Selamu, A Fekadu, C Lund, V Patel, I Petersen, ... Epidemiology and psychiatric sciences 26 (1), 43-52, 2017 | 55 | 2017 |
| An evaluation of the variation and underuse of clozapine in the United Kingdom E Whiskey, A Barnard, E Oloyede, O Dzahini, DM Taylor, SS Shergill Acta Psychiatrica Scandinavica 143 (4), 339-347, 2021 | 50 | 2021 |
| Clozapine and cardiotoxicity–a guide for psychiatrists written by cardiologists RK Patel, AM Moore, S Piper, M Sweeney, E Whiskey, G Cole, SS Shergill, ... Psychiatry research 282, 112491, 2019 | 49 | 2019 |
| Co-prescribing of atypical and typical antipsychotics–prescribing sequence and documented outcome D Taylor, S Mir, S Mace, E Whiskey Psychiatric Bulletin 26 (5), 170-172, 2002 | 47 | 2002 |
| The importance of the recognition of benign ethnic neutropenia in black patients during treatment with clozapine: case reports and database study E Whiskey, O Olofinjana, D Taylor Journal of psychopharmacology 25 (6), 842-845, 2011 | 46 | 2011 |
| Clozapine haematological monitoring for neutropenia: a global perspective E Oloyede, G Blackman, E Whiskey, C Bachmann, O Dzahini, S Shergill, ... Epidemiology and Psychiatric Sciences 31, e83, 2022 | 45 | 2022 |
| Clozapine-associated agranulocytosis treatment with granulocyte colony-stimulating factor/granulocyte-macrophage colony-stimulating factor: a systematic review J Lally, S Malik, E Whiskey, DM Taylor, FP Gaughran, A Krivoy, ... Journal of Clinical Psychopharmacology 37 (4), 441-446, 2017 | 43 | 2017 |
| <? covid19?> Management of clozapine treatment during the COVID-19 pandemic S Gee, F Gaughran, J MacCabe, S Shergill, E Whiskey, D Taylor Therapeutic Advances in Psychopharmacology 10, 2045125320928167, 2020 | 41 | 2020 |
| The use of granulocyte colony-stimulating factor in clozapine rechallenge: a systematic review J Lally, S Malik, A Krivoy, E Whiskey, DM Taylor, FP Gaughran, ... Journal of Clinical Psychopharmacology 37 (5), 600-604, 2017 | 41 | 2017 |
| The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust Prescribing Guidelines D Taylor, C Paton, S Kapur Informa Healthcare, 2009 | 41 | 2009 |
| When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity P Lowe, A Krivoy, L Porffy, E Henriksdottir, W Eromona, SS Shergill Therapeutic advances in psychopharmacology 8 (1), 63-70, 2018 | 38 | 2018 |
| Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis D Taylor, K Vallianatou, E Whiskey, O Dzahini, J MacCabe Schizophrenia 8 (1), 21, 2022 | 34 | 2022 |
| There is life after the UK clozapine central non-rechallenge database E Oloyede, C Casetta, O Dzahini, A Segev, F Gaughran, S Shergill, ... Schizophrenia Bulletin 47 (4), 1088-1098, 2021 | 33 | 2021 |
| Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe benign ethnic neutropaenia (BEN): a case report BWJ Spencer, HRJ Williams, SH Gee, E Whiskey, JP Rodrigues, A Mijovic, ... Journal of Psychopharmacology 26 (9), 1280-1282, 2012 | 29 | 2012 |
